Literature DB >> 9100148

AIDS clinical trials. Is there access for all?

L A Lynn.   

Abstract

Entities:  

Keywords:  Biomedical and Behavioral Research; Health Care and Public Health

Mesh：

Year:  1997        PMID： 9100148      PMCID： PMC1497089          DOI： 10.1007/s11606-006-5031-7

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  16 in total

Review 1.  Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication.

Authors:  K A Yonkers; J C Kando; J O Cole; S Blumenthal
Journal:  Am J Psychiatry       Date:  1992-05       Impact factor: 18.112

2.  Race, gender, drug use, and participation in AIDS clinical trials. Lessons from a municipal hospital cohort.

Authors:  V E Stone; M Y Mauch; K Steger; S F Janas; D E Craven
Journal:  J Gen Intern Med       Date:  1997-03       Impact factor: 5.128

Review 3.  Pharmacokinetic optimisation of antiretroviral therapy in patients with HIV infection.

Authors:  B N Stretcher
Journal:  Clin Pharmacokinet       Date:  1995-07       Impact factor: 6.447

4.  Race, ethnicity, and access to ambulatory care among US adolescents.

Authors:  T A Lieu; P W Newacheck; M A McManus
Journal:  Am J Public Health       Date:  1993-07       Impact factor: 9.308

5.  Physician discretion and racial variation in the use of surgical procedures.

Authors:  E A Mort; J S Weissman; A M Epstein
Journal:  Arch Intern Med       Date:  1994-04-11

6.  A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection.

Authors:  M Markowitz; M Saag; W G Powderly; A M Hurley; A Hsu; J M Valdes; D Henry; F Sattler; A La Marca; J M Leonard
Journal:  N Engl J Med       Date:  1995-12-07       Impact factor: 91.245

7.  Surrogate markers in AIDS clinical trials: conceptual basis, validation, and uncertainties.

Authors:  S W Lagakos
Journal:  Clin Infect Dis       Date:  1993-02       Impact factor: 9.079

8.  Racial and community factors influencing coronary artery bypass graft surgery rates for all 1986 Medicare patients.

Authors:  K C Goldberg; A J Hartz; S J Jacobsen; H Krakauer; A A Rimm
Journal:  JAMA       Date:  1992-03-18       Impact factor: 56.272

9.  Differences in laboratory values in HIV infection by sex, race, and risk group.

Authors:  R W Gorter; K M Vranizan; D H Osmond; A R Moss
Journal:  AIDS       Date:  1992-11       Impact factor: 4.177
View more
  1 in total

1.  Use of highly active antiretroviral therapy in a cohort of HIV-seropositive women.

Authors:  Judith A Cook; Mardge H Cohen; Dennis Grey; Lynn Kirstein; Jane Burke; Kathryn Anastos; Herminia Palacio; Jean Richardson; Tracey E Wilson; Mary Young
Journal:  Am J Public Health       Date:  2002-01       Impact factor: 9.308
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.